A Phase 3, Prospective, Randomized, Double-blind, Placebo-controlled, Multi-region Study to Evaluate the Efficacy, Safety, and Immunogenicity of Inactivated EV71 Vaccine Produced in Vero Cells With Adjuvant in Infants and Children
Phase of Trial: Phase III
Latest Information Update: 27 May 2019
Price : $35 *
At a glance
- Drugs Enterovirus A vaccine (Primary)
- Indications Enterovirus A infections
- Focus Registrational; Therapeutic Use
- Sponsors Medigen Biotechnology Corporation
- 23 May 2019 Status changed from not yet recruiting to recruiting.
- 04 Mar 2019 Status changed from planning to not yet recruiting.
- 28 Nov 2017 New trial record